Bind Therapeutics Company Profile (NASDAQ:BIND)

About Bind Therapeutics

Bind Therapeutics logoBIND Therapeutics, Inc. is a biotechnology company. The Company is engaged in developing targeted therapeutics, primarily for the treatment of cancer. The Company's product candidates are based on polymeric nanoparticles called ACCURINS, which are engineered to target specific cells and tissues in the body at sites of disease. ACCURINS are polymeric nanoparticles that incorporate therapeutic payloads with diverse physical and chemical properties, provide prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload. Its drug candidate, BIND-014, which has entered clinical development, is a prostate specific membrane antigen (PSMA)-targeted ACCURIN that contains docetaxel, a clinically validated cancer chemotherapy drug. It designs ACCURINS with specific pharmaceutical properties intended to target tumors at approximately three levels, such as tissue, cellular and molecular.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIND
  • CUSIP:
Key Metrics:
  • Previous Close: $0.78
  • 50 Day Moving Average: $0.5226
  • 200 Day Moving Average: $1.1668
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.72
  • P/E Growth: 0.0000
  • Market Cap: $N/A
  • Beta: 2.79
Additional Links:
Companies Related to Bind Therapeutics:

Analyst Ratings

Consensus Ratings for Bind Therapeutics (NASDAQ:BIND) (?)
Ratings Breakdown: 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $7.44 (851.70% upside)

Analysts' Ratings History for Bind Therapeutics (NASDAQ:BIND)
Show:
DateFirmActionRatingPrice TargetDetails
7/6/2016Stifel NicolausReiterated RatingHoldView Rating Details
4/7/2016JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
4/7/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
4/7/2016Oppenheimer Holdings Inc.DowngradeMarket PerformView Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$9.00 -> $6.00View Rating Details
12/4/2014Credit Suisse Group AGDowngradeOutperform -> Neutral$20.00 -> $10.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Bind Therapeutics (NASDAQ:BIND)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016        
5/9/2016Q116($0.55)($0.61)$3.83 million$1.87 millionViewListenView Earnings Details
3/15/2016Q415($0.49)($0.37)$3.35 million$6.40 millionViewListenView Earnings Details
11/2/2015Q315($0.52)($0.49)$3.14 million$2.10 millionViewN/AView Earnings Details
8/6/2015Q215($0.51)($0.51)$3.88 million$2.50 millionViewListenView Earnings Details
5/7/2015Q115($0.51)($0.44)$2.67 million$4.40 millionViewListenView Earnings Details
3/11/2015Q414($0.40)($0.51)$6.00 million$3.00 millionViewListenView Earnings Details
11/6/2014($0.31)($0.44)ViewN/AView Earnings Details
8/7/2014Q214($0.60)($0.51)$2.20 million$2.46 millionViewN/AView Earnings Details
5/9/2014($0.49)($0.51)ViewN/AView Earnings Details
3/25/2014($0.41)($0.50)ViewN/AView Earnings Details
11/5/2013Q313($0.67)($2.70)$1.66 million$4.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bind Therapeutics (NASDAQ:BIND)
Current Year EPS Consensus Estimate: $-1.4700 EPS
Next Year EPS Consensus Estimate: $-1.0900 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.61)($0.58)($0.60)
Q2 20162($0.48)($0.46)($0.47)
Q3 20162($0.48)($0.46)($0.47)
Q4 20162($0.49)($0.47)($0.48)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bind Therapeutics (NASDAQ:BIND)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bind Therapeutics (NASDAQ:BIND)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/25/2013Noubar AfeyanDirectorBuy20,000$15.00$300,000.00View SEC Filing  
9/25/2013Polaris Venture Management Co.Major ShareholderBuy26,000$15.00$390,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bind Therapeutics (NASDAQ:BIND)
DateHeadline
News IconPfizer Inc. (NYSE:PFE) Buys BIND’s Assets (NASDAQ:BIND)
learnbonds.com - August 25 at 3:54 PM
News IconWall Street Ratings and Update on BIND Therapeutics, Inc ... - Post News (NASDAQ:BIND)
www.kentuckypostnews.com - August 22 at 3:53 PM
4-traders.com logoDNIB Unwind : Bind Therapeutics reports 2Q loss (NASDAQ:BIND)
www.4-traders.com - August 16 at 12:34 PM
News IconFormer BIND Therapeutics CEO Joins Agios as New CFO (NASDAQ:BIND)
www.biospace.com - August 16 at 12:34 PM
sg.finance.yahoo.com logoBind Therapeutics reports 2Q loss (NASDAQ:BIND)
sg.finance.yahoo.com - August 16 at 12:34 PM
News IconBIND Therapeutics Inc (OTCMKTS:BINDQ): What Can Shareholder's Expect? - Insider Financial (NASDAQ:BIND)
www.insiderfinancial.com - August 3 at 3:53 PM
News IconIntraday Active Biotech Stocks News: Nektar Therapeutics (NASDAQ:NKTR), BIND Therapeutics, Inc. (NASDAQ:BIND) - The Voice Registrar (NASDAQ:BIND)
voiceregistrar.com - August 3 at 12:30 PM
prnewswire.com logoBiotech Stocks Technical Report -- Arena Pharma, BIND Therapeutics, Nektar Therapeutics, and Regeneron Pharma - PR Newswire (press release) (NASDAQ:BIND)
www.prnewswire.com - August 3 at 12:30 PM
biz.yahoo.com logoDNIB UNWIND, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:BIND)
biz.yahoo.com - August 2 at 9:30 PM
biz.yahoo.com logoBIND THERAPEUTICS, INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Amendments to Articles (NASDAQ:BIND)
biz.yahoo.com - August 2 at 8:39 AM
News IconHC Stocks Movements: BIND Therapeutics Inc (NASDAQ:BIND) Amedica Corporation (NASDAQ:AMDA) - share market updates (press release) (NASDAQ:BIND)
sharemarketupdates.com - August 1 at 8:46 AM
fortune.com logoAnalyst Ratings Worth Mentioning Today: Globalstar, Inc. (NYSEMKT:GSAT), BIND Therapeutics Inc (NASDAQ:BIND) - Review Fortune (NASDAQ:BIND)
reviewfortune.com - August 1 at 8:46 AM
streetupdates.com logoStock's Ratings to Focus: Skyline Medical Inc. (NASDAQ:SKLN) , BIND Therapeutics, Inc. (NASDAQ:BIND) - Street Updates (NASDAQ:BIND)
www.streetupdates.com - August 1 at 8:46 AM
streetupdates.com logoTraders Actions to Focus: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) , BIND Therapeutics, Inc. (NASDAQ:BIND) - Street Updates (NASDAQ:BIND)
www.streetupdates.com - July 29 at 7:40 AM
fortune.com logoNotable Brokerage Recommendations: Cliffs Natural Resources Inc (NYSE:CLF), BIND Therapeutics Inc (NASDAQ ... - Review Fortune (NASDAQ:BIND)
reviewfortune.com - July 28 at 4:55 PM
News IconRecommendation Trends of the Stock: BIND Therapeutics, Inc. (NASDAQ:BIND) - News Oracle (NASDAQ:BIND)
www.newsoracle.com - July 28 at 4:55 PM
biz.yahoo.com logoBIND THERAPEUTICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Notice of Delisting or Failure (NASDAQ:BIND)
biz.yahoo.com - July 28 at 4:07 PM
4-traders.com logoBIND Therapeutics : Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets (NASDAQ:BIND)
www.4-traders.com - July 28 at 12:36 PM
wsj.com logoPfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics (NASDAQ:BIND)
www.wsj.com - July 27 at 9:36 PM
law360.com logoBind Therapeutics Wins OK Of $40M Ch. 11 Sale to Pfizer (NASDAQ:BIND)
www.law360.com - July 27 at 9:36 PM
wsj.com logo[$$] Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics (NASDAQ:BIND)
www.wsj.com - July 27 at 12:55 PM
News IconSirius XM Holdings Inc. (NASDAQ:SIRI) & BIND Therapeutics (NASDAQ:BIND) Active Stock's Momentum - Money News (press release) (NASDAQ:BIND)
www.newsismoney.com - July 27 at 12:20 PM
reuters.com logoBRIEF-Bind Therapeutics determines Pfizer's $40 mln bid highest - Reuters (NASDAQ:BIND)
www.reuters.com - July 27 at 12:20 PM
News IconBind Therapeutics seeks court approval for $40m Pfizer bid - The Boston Globe (NASDAQ:BIND)
www.bostonglobe.com - July 27 at 12:20 PM
News IconNasdaq Composite Index May Have Diverged from Reality (Over-Bought?) (NASDAQ:BIND)
www.economiccalendar.com - July 26 at 9:48 PM
investing.com logoU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.10% (NASDAQ:BIND)
www.investing.com - July 26 at 9:48 PM
streetinsider.com logoBIND Therapeutics (BIND) Determines Pfizer's $40M Bid is Highest and Best (NASDAQ:BIND)
www.streetinsider.com - July 26 at 9:48 PM
businesswire.com logoBIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets (NASDAQ:BIND)
www.businesswire.com - July 26 at 9:48 PM
publicnow.com logoBIND Therapeutics Determines Pfizer's $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND's Assets (NASDAQ:BIND)
www.publicnow.com - July 26 at 5:48 PM
News IconStock Performance to Track: BIND Therapeutics, Inc. (NASDAQ:BIND) - News Oracle (NASDAQ:BIND)
www.newsoracle.com - July 26 at 3:42 PM
News IconBIND Therapeutics Inc (NASDAQ:BIND) Shareholders Are On Borrowed Time; Don't Get Caught Out - Insider Financial (NASDAQ:BIND)
www.insiderfinancial.com - July 26 at 3:42 PM
News IconIntraday Active Biotech Stocks News: BIND Therapeutics, Inc. (NASDAQ:BIND), Tobira Therapeutics, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:BIND)
voiceregistrar.com - July 26 at 11:26 AM
businesswire.com logoBIND Therapeutics Announces Two Bidders Join Pfizer's Stalking ... - Business Wire (press release) (NASDAQ:BIND)
www.businesswire.com - July 25 at 4:21 PM
streetinsider.com logoBIND Therapeutics (BIND) Announces Receipt of Two Competing Bids (PFE) (NASDAQ:BIND)
www.streetinsider.com - July 25 at 8:36 AM
businesswire.com logoBIND Therapeutics Announces Two Bidders Join Pfizer’s Stalking Horse Bid in Auction for BIND’s Assets (NASDAQ:BIND)
www.businesswire.com - July 25 at 8:36 AM
publicnow.com logoBIND Therapeutics Announces Two Bidders Join Pfizer's Stalking Horse Bid in Auction for BIND's Assets (NASDAQ:BIND)
www.publicnow.com - July 25 at 7:58 AM
News IconShares Stumbling of Late: BIND Therapeutics, Inc. (NASDAQ:BIND) - TGP (NASDAQ:BIND)
telanaganapress.com - July 23 at 3:47 PM
News IconEquity Roundup: Stock Performance Focus on BIND Therapeutics, Inc. (NASDAQ:BIND) - Press Telegraph (NASDAQ:BIND)
presstelegraph.com - July 23 at 8:04 AM
openpr.com logoNanoparticles Transforming Future of Novel Drug Delivery Systems in Cancer Therapy Market, says TMR (NASDAQ:BIND)
www.openpr.com - July 22 at 12:02 PM
fiscalstandard.com logoBIND Therapeutics, Inc. (NASDAQ:BIND) Current Analyst Ratings - Fiscal Standard (NASDAQ:BIND)
www.fiscalstandard.com - July 21 at 12:20 PM
News IconBind Therapeutics Incorporated (NASDAQ:BIND) Shorts Decreased by 75.83% After Short Covering - Consumer Eagle (NASDAQ:BIND)
www.consumereagle.com - July 20 at 10:44 PM
News IconBIND Therapeutics, Inc. (NASDAQ:BIND): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:BIND)
www.engelwooddaily.com - July 20 at 10:44 PM
News IconShares Moving Down on the Week: BIND Therapeutics, Inc. (NASDAQ:BIND) - Engelwood Daily (NASDAQ:BIND)
www.engelwooddaily.com - July 17 at 8:33 AM
fiscalstandard.com logoBIND Therapeutics, Inc. (NASDAQ:BIND) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BIND)
www.fiscalstandard.com - July 17 at 8:33 AM
News IconAre Analysts Bullish BIND Therapeutics Inc (NASDAQ:BIND) After Last Week? - Consumer Eagle (NASDAQ:BIND)
www.consumereagle.com - July 16 at 3:49 PM
News IconBIND Therapeutics, Inc. (NASDAQ:BIND) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:BIND)
www.engelwooddaily.com - July 13 at 9:15 PM
kcregister.com logoBIND Therapeutics, Inc. (NASDAQ:BIND) plummeted -7.41%: Vale S.A. (NYSE:VALE), Jacksonville Bancorp Inc ... - KC Register (NASDAQ:BIND)
www.kcregister.com - July 13 at 11:55 AM
ftsenews.co.uk logoBIND Therapeutics, Inc. (NASDAQ:BIND) Updated Price Targets - FTSE News (NASDAQ:BIND)
www.ftsenews.co.uk - July 13 at 11:55 AM
News IconBind Therapeutics Inc (NASDAQ:BIND) Q1 2016 Sentiment - Press Telegraph (NASDAQ:BIND)
presstelegraph.com - July 12 at 9:18 PM
wsj.com logo[$$] Pfizer Offers $20 Million for Bind Therapeutics Assets (NASDAQ:BIND)
www.wsj.com - July 6 at 9:20 AM

Social

Bind Therapeutics (NASDAQ:BIND) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff